About STACS DNA
STACS DNA is a Healthcare company based in Fairfax (United States) founded in 2005, and was acquired by InVita Healthcare Technologies in May 2021. STACS DNA offers products and services including STACS Casework, HemaConnect, iTransplant, and UDITracker. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Laboratory Management. Its competitors include Ovation, DDC Paternity Tests and Labvantage; 1 of its 3 listed competitors has raised funding.
Company details
Digital supply chains and sample tracking tool for hospitals. Products include STACS Sample Tracking and Control Software, STACS-CW Family of Solutions for Forensic DNA Casework Laboratories, STACS-DB Enterprise for Forensic DNA Database Laboratories, STACS-PM for Personalized Medicine Laboratories, and track Kit- a solution to trace samples and kits through their entire life cycle in the lab.
- Headquarters Fairfax, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website stacsdna.com
- Social LinkedIn X
- Acquired by InVita Healthcare Technologies (May 2021)
- Investors
- Acquired byInVita Healthcare Technologies
(May 2021)
Products & Services of STACS DNA
STACS DNA offers a comprehensive portfolio of products and services, including STACS Casework, HemaConnect, iTransplant, and UDITracker.
Tracks forensic DNA cases and investigations efficiently.
Manages blood and plasma sample processing securely.
Handles organ and tissue donation tracking systems.
Monitors implant lifecycles and warranties accurately.
Investors in STACS DNA
STACS DNA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include InVita Healthcare Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialized software solutions are provided for regulated healthcare industries. | 2016 | invitahealth.com | Baltimore, United States |
Investor details for STACS DNA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of STACS DNA
2 dated milestones of STACS DNA across 16 years, from founding to its latest funding, stage changes and deals.
- Founded STACS DNA is founded.
- Exit Acquired by InVita Healthcare Technologies.
Competitors of STACS DNA
STACS DNA has 3 listed competitors in our database, 1 of them funded. They include Ovation, DDC Paternity Tests and Labvantage.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ovation.io | 2009 | Cambridge, United States | $33.28M | 35 | Cloud-based platform for laboratory data management and collaboration is provided. | |
| dnacenter.com | 1995 | Fairfield, United States | DNA tests and personalized diagnostics are provided for various specialties. | |||
| labvantage.com | 1989 | Somerset, United States | 100 | LIMS, Quality ELN and Business Intelligence solutions for laboratory |
Detailed competitors of STACS DNA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as STACS DNA (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Stacs Dna
Complete news archive for STACS DNA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about STACS DNA
STACS DNA was founded in 2005.
STACS DNA is headquartered in Fairfax, United States. It is registered at Fairfax, Virginia, United States.
Digital supply chains and sample tracking tool for hospitals. Products include STACS Sample Tracking and Control Software, STACS-CW Family of Solutions for Forensic DNA Casework Laboratories, STACS-DB Enterprise for Forensic DNA Database Laboratories, STACS-PM for Personalized Medicine Laboratories, and track Kit- a solution to trace samples and kits through their entire life cycle in the lab.
STACS DNA's top competitors include Ovation, DDC Paternity Tests and Labvantage.
STACS DNA offers STACS Casework, HemaConnect, iTransplant, and UDITracker.
STACS DNA has 1 investor. Key investors include InVita Healthcare Technologies.
Yes. STACS DNA was acquired by InVita Healthcare Technologies in May 2021.

